140 related articles for article (PubMed ID: 9303188)
1. Antisense properties of end-modified oligonucleotides targeted to Ha-ras oncogene.
Saison-Behmoaras TE; Duroux I; Nguyen TT; Asseline U; Hélène C
Antisense Nucleic Acid Drug Dev; 1997 Aug; 7(4):361-8. PubMed ID: 9303188
[TBL] [Abstract][Full Text] [Related]
2. Short modified antisense oligonucleotides directed against Ha-ras point mutation induce selective cleavage of the mRNA and inhibit T24 cells proliferation.
Saison-Behmoaras T; Tocqué B; Rey I; Chassignol M; Thuong NT; Hélène C
EMBO J; 1991 May; 10(5):1111-8. PubMed ID: 1850694
[TBL] [Abstract][Full Text] [Related]
3. Rational design of point mutation-selective antisense DNA targeted to codon 12 of Ha-ras mRNA in human cells.
Duroux I; Godard G; Boidot-Forget M; Schwab G; Hélène C; Saison-Behmoaras T
Nucleic Acids Res; 1995 Sep; 23(17):3411-8. PubMed ID: 7567450
[TBL] [Abstract][Full Text] [Related]
4. Antisense oligonucleotides adsorbed to polyalkylcyanoacrylate nanoparticles specifically inhibit mutated Ha-ras-mediated cell proliferation and tumorigenicity in nude mice.
Schwab G; Chavany C; Duroux I; Goubin G; Lebeau J; Hélène C; Saison-Behmoaras T
Proc Natl Acad Sci U S A; 1994 Oct; 91(22):10460-4. PubMed ID: 7937975
[TBL] [Abstract][Full Text] [Related]
5. Nuclease resistance and antisense activity of modified oligonucleotides targeted to Ha-ras.
Monia BP; Johnston JF; Sasmor H; Cummins LL
J Biol Chem; 1996 Jun; 271(24):14533-40. PubMed ID: 8662854
[TBL] [Abstract][Full Text] [Related]
6. The antisense c-Ha-ras oligodeoxynucleotides inhibit the proliferation of the gastrocarcinoma-DNA-transformed rat 3-3 cells and reduce the p21 expression of the cells.
Xu Y; Deng GR; Liang YY; Li C
Sci China B; 1991 Jan; 34(1):35-41. PubMed ID: 2015062
[TBL] [Abstract][Full Text] [Related]
7. Antisense oligonucleotides.
Herdewijn P
Verh K Acad Geneeskd Belg; 1996; 58(4):359-81. PubMed ID: 8956554
[TBL] [Abstract][Full Text] [Related]
8. Hybridization specificity, enzymatic activity and biological (Ha-ras) activity of oligonucleotides containing 2,4-dideoxy-beta-D-erythro-hexopyranosyl nucleosides.
Augustyns K; Godard G; Hendrix C; Van Aerschot A; Rozenski J; Saison-Behmoaras T; Herdewijn P
Nucleic Acids Res; 1993 Oct; 21(20):4670-6. PubMed ID: 7694231
[TBL] [Abstract][Full Text] [Related]
9. Oligonucleotide treatment of ras-induced tumors in nude mice.
Wickstrom E
Mol Biotechnol; 2001 May; 18(1):35-55. PubMed ID: 11439698
[TBL] [Abstract][Full Text] [Related]
10. The synthesis and biological activities of oligodeoxynucleotides that are covalently linked to psoralen at their 5' ends.
Wang LX; Yang DC; Lu YY; Takagi Y; Taira K; Li T; Zhang LH
Drug Des Discov; 1995 Nov; 13(2):109-21. PubMed ID: 8872455
[TBL] [Abstract][Full Text] [Related]
11. Selective inhibition of mutant Ha-ras mRNA expression by antisense oligonucleotides.
Monia BP; Johnston JF; Ecker DJ; Zounes MA; Lima WF; Freier SM
J Biol Chem; 1992 Oct; 267(28):19954-62. PubMed ID: 1400312
[TBL] [Abstract][Full Text] [Related]
12. [Oligonucleotides complementary to the mRNA of the c-HA-ras gene suppress human cell proliferation in culture].
Debus N; Griaznov SM; Berdichevskiĭ FB
Dokl Akad Nauk SSSR; 1990; 313(2):491-4. PubMed ID: 2289400
[No Abstract] [Full Text] [Related]
13. Evaluation of 2'-modified oligonucleotides containing 2'-deoxy gaps as antisense inhibitors of gene expression.
Monia BP; Lesnik EA; Gonzalez C; Lima WF; McGee D; Guinosso CJ; Kawasaki AM; Cook PD; Freier SM
J Biol Chem; 1993 Jul; 268(19):14514-22. PubMed ID: 8390996
[TBL] [Abstract][Full Text] [Related]
14. Photochemically and chemically activatable antisense oligonucleotides: comparison of their reactivities towards DNA and RNA targets.
Godard G; François JC; Duroux I; Asseline U; Chassignol M; Nguyen T; Hélène C; Saison-Behmoaras T
Nucleic Acids Res; 1994 Nov; 22(22):4789-95. PubMed ID: 7527139
[TBL] [Abstract][Full Text] [Related]
15. Antisense oligonucleotides demonstrate a dominant role of c-Ki-RAS proteins in regulating the proliferation of diploid human fibroblasts.
Chen G; Oh S; Monia BP; Stacey DW
J Biol Chem; 1996 Nov; 271(45):28259-65. PubMed ID: 8910444
[TBL] [Abstract][Full Text] [Related]
16. Target dependence of antisense oligodeoxynucleotide inhibition of c-Ha-ras p21 expression and focus formation in T24-transformed NIH3T3 cells.
Daaka Y; Wickstrom E
Oncogene Res; 1990; 5(4):267-75. PubMed ID: 2204019
[TBL] [Abstract][Full Text] [Related]
17. [Mechanism for suppression mRNA translation with antisense oligonucleotides].
Vlasov VV; Iurchenko LV
Mol Biol (Mosk); 1990; 24(5):1157-61. PubMed ID: 2290415
[TBL] [Abstract][Full Text] [Related]
18. Antisense DNA inhibition of tumor growth induced by c-Ha-ras oncogene in nude mice.
Gray GD; Hernandez OM; Hebel D; Root M; Pow-Sang JM; Wickstrom E
Cancer Res; 1993 Feb; 53(3):577-80. PubMed ID: 8425190
[TBL] [Abstract][Full Text] [Related]
19. Antisense PNA tridecamers targeted to the coding region of Ha-ras mRNA arrest polypeptide chain elongation.
Dias N; Dheur S; Nielsen PE; Gryaznov S; Van Aerschot A; Herdewijn P; Hélène C; Saison-Behmoaras TE
J Mol Biol; 1999 Nov; 294(2):403-16. PubMed ID: 10610767
[TBL] [Abstract][Full Text] [Related]
20. The influence of target protein half-life on the effectiveness of antisense oligonucleotide analog-mediated biologic responses.
Spiller DG; Giles RV; Broughton CM; Grzybowski J; Ruddell CJ; Tidd DM; Clark RE
Antisense Nucleic Acid Drug Dev; 1998 Aug; 8(4):281-93. PubMed ID: 9743466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]